- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.06. | Wellgistics-Führungskräfte üben Warrants für 200.000 Aktien aus | 1 | Investing.com Deutsch | ||
| 30.06. | Wellgistics executives exercise warrants for 200,000 shares | 2 | Investing.com | ||
| 30.06. | Wellgistics Health, Inc.: Wellgistics Health Executive Chairman and President Exercise Warrants | 331 | ACCESS Newswire | Executives exercise previously issued warrants to acquire 200,000 common sharesShares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 2026... ► Artikel lesen | |
| WELLGISTICS HEALTH Aktie jetzt für 0€ handeln | |||||
| 26.06. | DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc. | 361 | ACCESS Newswire | Name reflects vertically-aligned healthcare ecosystem business model integrating data captured via telemedicine, online pharmacy, lab tests and wearables to perfect patients' digital health twins in... ► Artikel lesen | |
| 12.06. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Wellgistics Health, Inc.: Wellgistics Health Provides Mid-Year 2026 Corporate Outlook | 402 | ACCESS Newswire | Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late... ► Artikel lesen | |
| 29.05. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.05. | Wellgistics: Aktionäre vereinbaren 90-tägige Sperrfrist für Aktien | 2 | Investing.com Deutsch | ||
| 28.05. | Wellgistics shareholders agree to 90-day share lock-up | 5 | Investing.com | ||
| 28.05. | Wellgistics Health, Inc.: Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock | 422 | ACCESS Newswire | Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader,... ► Artikel lesen | |
| 28.05. | Wellgistics Health, Inc.: Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M | 729 | ACCESS Newswire | New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes... ► Artikel lesen | |
| 26.05. | Wellgistics Health, Inc.: Wellgistics Health Completes Reverse Split | 495 | ACCESS Newswire | 1-for-50 reverse split of common shares outstanding now complete2,513,425 common shares now outstandingA new CUSIP was issued in connection with reverse split TAMPA, FL / ACCESS Newswire / May 26, 2026... ► Artikel lesen | |
| 21.05. | Wellgistics Health, Inc.: Wellgistics Health Releases Letter to Our Shareholders | 557 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization... ► Artikel lesen | |
| 21.05. | Why Wellgistics Health (WGRX) Stock Fell Over 24% After Hours? | 3 | Benzinga.com | ||
| 21.05. | Wellgistics Health announces 1-for-50 reverse stock split to regain Nasdaq compliance | 6 | Seeking Alpha | ||
| 21.05. | Wellgistics Health approves 1-for-50 reverse stock split | 2 | Investing.com | ||
| 21.05. | Wellgistics Health, Inc.: Wellgistics Health Announces Reverse Stock Split | 558 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / May 20, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a health information technology leader, integrating proprietary pharmacy dispensing... ► Artikel lesen | |
| 19.05. | Wellgistics Health GAAP EPS of -$0.07 | 1 | Seeking Alpha | ||
| 19.05. | Wellgistics Health, Inc.: Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update | 597 | ACCESS Newswire | Wellgistics Pharmacy monthly revenue increased from approximately $0.1 million in November 2025 to approximately $0.6 million in April 2026, based on preliminary unaudited resultsQ1-26 focus on optimization... ► Artikel lesen | |
| 19.05. | Wellgistics Health, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings |
1 2 3 4 5 Weiter >>
85 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TILRAY BRANDS | 3,875 | +1,17 % | Tilray Brands, Inc.: BrewDog Waterloo to Host England's Biggest Pub Watch Party for Blockbuster Semifinal | England's biggest pub comes alive for a blockbuster semifinal, delivering the atmosphere, the passion and an unforgettable football watch party as fans rally behind England
LONDON, July 13, 2026... ► Artikel lesen | |
| VIATRIS | 14,432 | +1,02 % | Mylan exits Biocon with Rs 3,679 crore block deal; ICICI Prudential MF emerges largest buyer | ||
| SYNBIOTIC | 1,282 | +2,40 % | SYNBIOTIC SE: Portfoliobereinigung setzt die Basis neu; Kursziel gesenkt, bleibt jedoch Spek. KAUFEN | SYNBIOTIC stellt sein Portfolio neu auf, nachdem Hempro International, HANF FARM und Hemp Factory in Richtung Liquidation und/oder Insolvenz gehen, bedingt durch einen starken Rückgang der Nachfrage... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 9,850 | +1,76 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA | New agreement, effective January 1, 2027, to add approximately 9 million Medicare lives (16% of approximately 55 million Medicare lives in the U.S.) On top of two previously announced major commercial... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 11,800 | +0,43 % | DesignRush: Brooke Sellas Joins DesignRush Podcast on Social Media's Revenue Risk | Miami, Florida--(Newsfile Corp. - June 23, 2026) - The latest episode of the DesignRush Podcast features Brooke Sellas, founder and CEO of B Squared Media. The episode explores why companies risk... ► Artikel lesen | |
| XORTX THERAPEUTICS | 1,756 | -2,39 % | XORTX Therapeutics Inc.: XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange | CALGARY, Alberta, June 12, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | |
| SOLIGENIX | 0,370 | -0,03 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and First Quarter 2026 Financial Results | PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
| TALPHERA | 1,270 | +3,25 % | Talphera, Inc.: Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update | NEPHRO CRRT clinical study expected to be completed this year
Cash and investments of $21.1 million at March 31, 2026
Conference call and webcast to be held on Wednesday... ► Artikel lesen | |
| SAVARA | 4,860 | -2,80 % | Savara Inc.: Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) | -- MHRA's Acceptance Follows Acceptance/Validation of MOLBREEVI Biologics License Application (BLA) and MAA in Autoimmune PAP by the U.S. Food and Drug Administration (FDA) and the European Medicines... ► Artikel lesen | |
| SCYNEXIS | 4,940 | +0,20 % | XFRA 135: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSCYNEXIS INC. DL... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,240 | 0,00 % | Theriva Biologics, Inc.: Theriva Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal | - VIRAGE2 exploratory study designed to refine dosing regimen to potentially improved outcomes in a future pivotal Phase 3 clinical trial -
- Study builds on positive clinical data from the recent... ► Artikel lesen | |
| WAVE LIFE SCIENCES | 5,300 | -1,85 % | Wave Life Sciences Ltd.: Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation | CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential... ► Artikel lesen | |
| TUHURA BIOSCIENCES | 2,140 | +2,88 % | TuHURA Biosciences, Inc.: TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers | The IND is aligned with guidance previously provided by the U.S. Food and Drug Administration (FDA) on the development pathway for both monotherapy and combination... ► Artikel lesen | |
| THERAPEUTICSMD | 1,650 | -0,60 % | TherapeuticsMD, Inc. - 8-K, Current Report | ||
| SKYE BIOSCIENCE | 0,540 | 0,00 % | Skye Bioscience, Inc.: Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1 | SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic... ► Artikel lesen |
Das Unternehmen WELLGISTICS HEALTH INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 2,985 Euro und damit +1,88 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WELLGISTICS HEALTH INC finden Sie auf Wallstreet Online.